Due to the pivotal role of PKM2 in glycometabolism and various cellular processes of tumor cells, targeting PKM2 might be an ideal therapeutic strategy for malignant tumors that are characterized by infinite proliferation, metastasis and chemoresistance. This evidence concerns the gene PKM and neoplasm.